Comparative physicochemical and structural characterisation studies establish high biosimilarity between BGL‑ASP and reference insulin aspart
Diabetes drug-maker USV marks entry into insulin with biosimilar of Insulin Aspart
USV Partners With Biogenomics To Launch INSUQUICK, The First Biosimilar Insulin Aspart for People with Diabetes In India
USV, Biogenomics launch INSUQUICK, biosimilar Insulin Aspart for diabetes treatment
USV partners with Biogenomics to launch biosimilar insulin aspart for diabetes in India
USV partners with Biogenomics to launch first biosimilar Insulin Aspart for diabetics In India
USV Launches INSUQUICK, First Biosimilar Insulin Aspart in India
